News & Media

Formulytica conferences 2024

Formulytica Conference Schedule for 2024

Formulytica are pleased to share our itinerary of local and international conferences that our team will be attending in... read more

Media Release: Proposed Acquisition by Opal Biosciences

Please read the attached announcement jointly issued by Opal and Formulytica of the proposed merger. 23-06-21 Opal – FLT Acquisition read more

Formulytica to Exibit at the Annual ARCS 2023 Conference

Formulytica will be participating in the Australian Association of Regulatory and Clinical Scientists (ARCS) 2023 Annual Conference. This event... read more

Formulytica formulation scientists to attend ASCC conference May 2023

Meet our team at the 55th annual ASCC conference

Our team of formulation scientists are proud to be representing Formulytica at the upcoming 55th annual The Australian Society... read more

Formulytica poised to develop clinical-ready formulations of psilocybin and MDMA

Formulytica is pleased to announce that it has been granted a licence from the Victorian Department of Health enabling... read more

Formulation Lab

New international patent application

Formulytica and Singapore Eye Research Institute (SERI) are pleased to announce that an international (PCT) patent application was filed... read more

Our summer interns 2019-2020

Formulytica has hosted 3 Monash University students for their industry internship. These students are from various backgrounds such as... read more

Formulytica participates in the Third Precision Medicine & Medical Care and Aging International Forum in Tianjin, China, December 7-8

Our CEO, Dr Richard Buchta, joined with other international delegates at the Third Precision Medicine & Medical Care and... read more

Austrade delegation at Taiwan Healthcare Expo, December 5-8

Formulytica joined with the Australian Biomedical & Digital Health Showcase hosted by Austrade Taipei as part of the 2019... read more

Richard Buchta to speak at Biotech Development Lab “Formula for Success”, September 13

Formulation is key to the success of any pharmaceutical product. Formulytica’s CEO Dr Richard Buchta will speak about what... read more

Formulytica offers liposomal formulation development services

As part of Formulytica’s expanding offerings in injectable and topical formulation development services, we are pleased to announce that... read more

Formulytica attends BIO Asia-Taiwan Conference and Exhibition, July 24-28

Formulytica is attending the 2019 BIO Asia-Taiwan International Conference and Exhibition in Taipei, July 24-28 as part of the... read more